Product
SHR-2010
2 clinical trials
1 indication
Indication
IgA NephropathyClinical trial
A Phase II Seamless Design, Randomized, Double-blind, Placebo-controlled, Dose-exploration Study Evaluate the Efficacy and Safety of SHR-2010 Injection in Patients With Primary IgA NephropathyStatus: Recruiting, Estimated PCD: 2026-01-30
Clinical trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous/Subcutaneous Injection of SHR-2010 in Healthy Subjects: a Randomized, Double-blind, Dose-increasing, Placebo-controlled Phase I Clinical TrialStatus: Completed, Estimated PCD: 2023-03-10